Stock 4117 GENERAL BIOLOGICALS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News General Biologicals Corporation

Equities

4117

TW0004117007

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 02/07/2024 am IST 		5-day change 1st Jan Change
22.75 TWD +0.66% Intraday chart for General Biologicals Corporation +7.31% -15.74%
30/04 General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2023
CI
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
CI
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2022
CI
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
CI
General Biologicals Corporation(TPEX:4117) dropped from S&P Global BMI Index
CI
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2021
CI
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2020
CI
General Biologicals Corporation completed the acquisition of additional 77% stake in Pacgen Life Science Corporation.
CI
General Biologicals Corporation(TPEX:4117) added to S&P Global BMI Index
CI
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2020
CI
General Biologicals Corporation announced that it has received TWD 77.623729 million in funding from Hong Kong Chlitina International Limited
CI
General Biologicals Corporation entered into a letter of intent to acquire additional 77% stake in Pacgen Life Science Corporation for CAD 1.4 million.
CI
General Biologicals Corporation Announces Develops Covid-19 Testing Solutions for Antigen and Antibody Detection
CI
Savior Lifetec : Taiwanese companies fill US demand for medical supplies amid pandemic
AQ
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2019
CI
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2019
CI
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2018
CI
General Biologicals Corporation Adds New Markets for P113 Products Licensed from Pacgen
CI
GBC Introduces its New Discovery Line of Document Cameras
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4117 Stock
  4. News General Biologicals Corporation